Sign Up Now to Download a Free Research Report on
Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts
Having problems viewing PDF files? Spectrum Pharmaceuticals, Inc.
Spectrum Pharmaceuticals shares plunged 37.33 percent on over 22.5 million shares traded Wednesday to close at $7.79 a share. The company “anticipates a change in ordering patterns of FUSILEV” and sales for the first quarter are expected to be approximately $10 to $15 million.
Going forward ... (see research report)
Subscribe to News Feeds